Monurol (Fosfomycin)

Fosfomycin inhibits bacterial cell‑wall synthesis by blocking the MurA enzyme, which is essential for the formation of N‑acetylmuramic acid, a key building block of peptidoglycan. This interruption weakens the bacterial wall, leading to cell lysis and death, particularly against many Gram‑negative uropathogens.

The dosage of Monurol is determined by the prescribing clinician based on the patient’s condition, renal function, and local guidelines. In most cases a single oral dose is administered, but the exact amount and any repeat dosing must be specified by a qualified healthcare professional.

Safety data for fosfomycin in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. Women who are pregnant or breastfeeding should discuss use of Monurol with their physician before starting treatment.

To request Monurol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, and will ask you to confirm trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Compared with nitrofurantoin or trimethoprim‑sulfamethoxazole, fosfomycin offers a single‑dose regimen and retains activity against many multidrug‑resistant uropathogens. However, its spectrum is narrower, and resistance can develop if used repeatedly. Choice of therapy should be guided by local susceptibility patterns and patient‑specific factors.

Monurol tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or extreme heat.

Monurol is taken orally, usually as a single tablet with a full glass of water. It is often recommended to take the dose on an empty stomach, at least 30 minutes before or 2 hours after a meal, to maximize absorption. Follow the prescribing clinician’s instructions for timing.

The most serious adverse reactions include severe allergic responses such as rash, itching, swelling, or anaphylaxis, and Clostridioides difficile‑associated colitis presenting as persistent watery diarrhea. Signs of liver dysfunction (jaundice, dark urine) or severe skin reactions (Stevens‑Johnson syndrome) also require immediate medical attention.

Monurol should be avoided in individuals with a known hypersensitivity to fosfomycin or any component of the formulation. Patients with severe renal impairment may require dose adjustment or alternative therapy. It is also contraindicated in those who have experienced serious allergic reactions to other antibiotics in the same class.